etilevodopa

is the ethyl ester of levodopa; an antiparkinson drug

Networked: 3 relevant articles (2 outcomes, 1 trials/studies)

1.	Myopia 10/04/2021 - "These findings indicate the potential of topical etilevodopa and dopamine for further study as a therapeutic treatment for myopia."
2.	Dyskinesias (Dyskinesia) 02/01/2006 - "Total daily "off" time improved in the etilevodopa-carbidopa (-0.85 hour) and levodopa-carbidopa (-0.87 hour) groups without an increase in on time with troublesome dyskinesias. "
3.	Parkinson Disease (Parkinson's Disease) 02/01/2006 - "A randomized controlled trial of etilevodopa in patients with Parkinson disease who have motor fluctuations." 11/01/2003 - "Pharmacokinetics of etilevodopa compared to levodopa in patients with Parkinson's disease: an open-label, randomized, crossover study."